{"lastClose": 1.399999976158142, "len": 472, "date": "2023-03-02", "alpha_1": -0.5392803872118181, "beta_1": 2.5215342555583566, "drawup_1": 0.6999999674883763, "natr_1": 33.16917306901818, "sup_1": -0.39999993755703755, "res_1": 0.5571429029613945, "bullPattern_1": ["HAMMER"], "bearPattern_1": [], "rsi_1": 38.33992070650678, "adx_1": 11.415139464649188, "drawdown_1": -0.6949891220877613, "stratHoldSharpe_1": -0.6389755331666733, "stratHoldAlpha_1": 250.4447950688511, "stratHoldDrawdown_1": -0.6301580492203106, "alpha_3mo": -0.14122295514663774, "beta_3mo": 2.615275118210557, "drawup_3mo": 0.44078952940877514, "natr_3mo": 33.16917306901818, "sup_3mo": -0.10952379208843695, "res_3mo": 0.07380953982573815, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 26.02739233889148, "adx_3mo": 59.911400493530785, "drawdown_3mo": -0.36073062119686994, "stratHoldSharpe_3mo": -0.9600058414046719, "stratHoldAlpha_3mo": 250.304683797211, "stratHoldDrawdown_3mo": -0.33054395979067974, "Market Cap": 2864548278, "Country": "United States", "Name": "Ginkgo Bioworks Holdings Inc. Class A", "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2021.0, "alpha%_1": 0.06072939009139606, "beta%_1": 0.9987896087197239, "drawup%_1": 0.6560027409496485, "natr%_1": 1.0, "drawdown%_1": 0.05117174376137123, "stratHoldSharpe%_1": 0.1638977216434216, "stratHoldAlpha%_1": 0.011919349115857378, "stratHoldDrawdown%_1": 0.05421087266312768, "alpha%_3mo": 0.21262643956355304, "beta%_3mo": 0.9969587574528271, "drawup%_3mo": 0.8610173509554075, "natr%_3mo": 1.0, "drawdown%_3mo": 0.005456529355567636, "stratHoldSharpe%_3mo": 0.17212107999333764, "stratHoldAlpha%_3mo": 0.051489453458494455, "stratHoldDrawdown%_3mo": 0.004978208776386669}